Information  X 
Enter a valid email address

Essentra plc (ESNT)

  Print      Mail a friend       Annual reports

Friday 02 November, 2018

Essentra plc

Director/PDMR Shareholding

RNS Number : 1819G
Essentra plc
02 November 2018
 

 

Notification and public disclosure of transactions by persons discharging managerial responsibility

The notification made on behalf of Persons Discharging Managerial Responsibility ('PDMRs') under article 19.1 of the Market Abuse Regulation ('MAR') relates to transactions made on behalf of Lorraine Trainer a Director, in Essentra plc.

This announcement is made in accordance with Article 19.3 of MAR

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Lorraine Trainer

2

 

Reason for the notification

·    Purchase of shares via the Company's Dividend ReInvestment Plan

 

a)

 

Position/status

 

 

Non Executive Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Essentra plc

b)

 

LEI

 

 

5493007MOZNA03BVNE96

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 25p shares



Identification code

GB00B0744359



b)

 

Nature of the transaction

 

 

Purchase of shares

 

c)

 

Price(s) and volume(s)









 



Price (£)

Volume

 



3.823

139

 




 

d)

 

Aggregated information




- Aggregated volume

139



- Price

£531.40



e)

 

Date of the transaction

 

 

31 October 2018

f)

 

Place of the transaction

London Stock Exchange (XLON)

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHUGGPUGUPRGUP

a d v e r t i s e m e n t